Year: 2020

Columbus, OH, Nov. 12, 2020 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the Wolfe Research Virtual Healthcare Conference on Wednesday, November 18, 2020, at 3:10 p.m. Eastern Time.  To hear a live webcast of the presentation, visit the investor relations page on the Company’s Web site at www.mt.com/investors.  A replay of the webcast will be available for seven days.Mary T. Finnegan Investor Relations +1-614-438-4748

HOUSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) — Crown Castle International Corp. (NYSE: CCI) (“Crown Castle”) announced today that Jay Brown, Crown Castle’s President and Chief Executive Officer, will present at one investor conference in November and Dan Schlanger, Crown Castle’s Executive Vice President and Chief Financial Officer, will present at two investor conferences in November. The presentations will be broadcast over the Internet, and the live audio webcast links will be available on Crown Castle’s website at www.crowncastle.com, where they will also be archived for replay.Mr. Schlanger is scheduled to present on Tuesday, November 17, 2020 at 10:20 a.m. Eastern Time at the New Street 2020 Conference: 5G. Infrastructure. Applications. Innovation. Disruption. The presentation is expected to last approximately 30 minutes.Mr....

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today presented preclinical data on HPN601 for the treatment of solid tumors at the 35th Society for Immunotherapy of Cancer (SITC) virtual annual meeting. HPN601 is the first conditionally active T cell engager program from Harpoon. It targets the tumor antigen epithelial cell adhesion molecule (EpCAM) and is based on Harpoon’s proprietary ProTriTAC™ T cell engager prodrug platform designed to remain inert systemically until its activation in the tumor by tumor-associated proteases and to enable the safe targeting of broadly expressed tumor antigens.The oral presentation today highlighted the following data:The successful use of a humanized rodent tumor...

Holmdel, NJ, Nov. 12, 2020 (GLOBE NEWSWIRE) — Monmouth Real Estate Investment Corporation (NYSE:MNR) today announced that Michael P. Landy, President and Chief Executive Officer, Kevin Miller, Chief Financial Officer, and Becky Coleridge, Vice President of Investor Relations, are scheduled to participate in Nareit’s REITworld: 2020 Virtual Annual Conference.Monmouth is scheduled to present on Tuesday, November 17, 2020, at 9:30 a.m. Eastern Time.In order to view the presentation live or on-demand, you must register on the REITworld website.Monmouth Real Estate Investment Corporation, founded in 1968, is one of the oldest public equity REITs in the world. The Company specializes in single tenant, net-leased industrial properties, subject to long-term leases, primarily to investment-grade tenants. Monmouth Real Estate is a fully integrated...

RUTHERFORD, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced today financial and operating results for the quarter ended September 30, 2020.RECENT STRATEGIC AND OPERATIONAL HIGHLIGHTSJohn A. Roberts, Chief Executive Officer of Cancer Genetics stated, “During Q3 2020, we continued to make advances to enhance value for our shareholders and customers. The key event of the quarter was signing a definitive agreement to merge with StemoniX. Based on our lengthy search for a merger partner since last year, StemoniX proved to be the most attractive opportunity for our shareholders by extracting meaningful value from synergies with our vivoPharm drug discovery business and the continued transformation of...

Charlotte, NC, Nov. 12, 2020 (GLOBE NEWSWIRE) — Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company”) today announced financial results for the third quarter and nine months ended September 30, 2020.Financial and Operational Highlights          ●     Convergent profitability improved with continued growth in recurring revenue                        ○     Year-over-year segment gross margins increased to 47.9% from 32.4%, segment operating income improved by 169% and segment Adjusted EBITDA grew 88% to $1.7 million          ●     Strong Entertainment began to see meaningful signs of recovery as cinema exhibitors and other entertainment operators began reopening worldwide                        ○     Revenue decreased year over year due to COVID-19 impact on cinema operators                                                        ...

DENVER, Nov. 12, 2020 (GLOBE NEWSWIRE) — StoneCastle Financial Corp. (Nasdaq: BANX) (“StoneCastle Financial” or the “Company”), an investment company registered with the Securities and Exchange Commission (“SEC”), today announced results for the third fiscal quarter ended September 30, 2020.Third Quarter 2020 Investment Highlights:Invested approximately $23.7 million in three investmentsRealized proceeds of $45.9 million from the sale of two investmentsRealized proceeds from partial paydowns of $3.9 million from five investmentsA complete listing of investments as of the end of the quarter can be found on the Company’s website at www.stonecastle-financial.com.Subsequent to the end of the quarter, the Company invested $13.7 million in two investments.The estimated annualized yield generated by the invested portfolio as of September...